Form D · Biotechnology
Microstructure Imaging, Inc.
New York, NY · CIK 0001991242
Offering snapshot reported Aug 24, 2023 · SEC filing
- Reported sold
- $590K Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Aug 2, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 24, 2023 | Initial | $590,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-490631
All Securities represent SAFEs and only SAFEs are being offered at this time and only to verified accredited investors.
Source: Form D, filed Aug 24, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Benjamin Ades Aron | Director, Executive |
| Gregory Lemberskiy Lemberskiy | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
600 Third Avenue Second Floor
New York, NY, 10016
New York, NY, 10016